GE HealthCare Technologies Inc. (GEHC): price, analyst ratings, earnings and fundamentals

Updated 16 September 2026, 08:02 ET

GE HealthCare Technologies Inc. (GEHC) closed at $64.07 on 15 September 2026, down 0.3%. The stock is down 13.1% over one month and down 16.2% over one year. It trades 28.6% below its 52-week high of $89.77. Analysts recorded 10 actions in the last 90 days; the median price target of $78 is 21.7% above the last close. The company last reported on 29 July 2026 for Q2 2026: EPS of $1.13 against an estimate of $1.04, a beat of 8.6%, on revenue of $5.3 billion.

Price and performance

Performance figures use dividend and split adjusted closes over trading sessions, so a one-year move compares the last close with the close 252 sessions earlier. The 52-week range uses the adjusted daily highs and lows of the same window. Read the guide: Momentum, trend and technical indicators.

The live chart with technical indicators is in the app: open GEHC in FundSpec.

Analyst ratings

Over the last 90 days FundSpec recorded 10 analyst actions on GEHC from 8 firms: 7 maintained or reiterated a view and 3 initiations. Price targets were 5 raised and 1 lowered. The most recent targets from 13 firms range from $14 to $90, with a median of $78, 21.7% above the last close.

A price target is one firm's twelve-month view, and the median across firms is a steadier reading than any single call. Upgrades and downgrades matter more when they change a rating, not only a target. Read the guide: What analyst ratings and price targets actually tell you.

Every action with the firm's history is in Analyst Ratings.

Earnings

The next report is scheduled for 28 October 2026 before the open for Q3 2026, with EPS expected at $1.21 on revenue of $5.4 billion. GE HealthCare Technologies Inc. beat the EPS estimate in 7 of its last 8 reported quarters.

An earnings surprise is the reported EPS against the consensus estimate on the day. The price reaction depends as much on guidance and on what was already priced in as on the surprise itself. Read the guide: Earnings season: estimates, surprises and price reaction.

Estimates, confirmed dates and alerts for every company are in Earnings.

Fundamentals

On a trailing twelve month basis the company shows revenue growth of N.A., a gross margin of N.A., an operating margin of N.A. and a return on equity of N.A..

Margins and returns say how much of each dollar of sales becomes profit and how hard the balance sheet is working; leverage and liquidity say how much room the company has when conditions turn. Read the guide: A practical guide to discounted cash flow valuation.

Fair value, peer multiples and the full statement history are in the app: open GEHC in FundSpec.

SEC filings

The latest filing is a 10-Q from 29 July 2026.

Company profile

Exchange

Nasdaq

Sector

Manufacturing

Industry

Medical Equipment

Chief executive

Peter J. Arduini

Employees

50,000

SEC CIK

0001932393

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator. It serves customers in more than 160 countries with a global team of over 10,000 sales representatives, 8,500 field service engineers and 43 manufacturing sites across 17 countries.

Sector and peers

GE HealthCare Technologies Inc. is part of the Manufacturing sector, which FundSpec tracks across 1 company.

Companies in the same industry by market capitalization:

MDLN Medline Inc.

Put two of them side by side in Compare.